CoChat

Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial

Open access
Abraham, Mary B., de Bock, Martin, Smith, Grant J., Dart, Julie, Fairchild, Janice M., King, Bruce R., Ambler, Geoffrey R., Cameron, Fergus J., McAuley, Sybil A., Keech, Anthony C., Jenkins, Alicia, Davis, Elizabeth A., O’Neal, David N., Jones, Timothy W., Australian Juvenile Diabetes Research Fund Closed-Loop Research group, Choo, Ace, Nicholas, Jennifer, Laurenson, Leah, Roberts, Alison, Bebbingtom, Keely, Klimek, Julie, Heels, Kristine, Gebert, Rebecca, Johnson, Shaun, Oats, Stephanie, Rafferty, Jordan, Pease, Anthony, Zoungas, Sophia, Lee, Melissa H, Paldus, Barbora, Sims, Catriona M, MacIssac, Richard J, Ward, Glenn M, Colman, Peter G, Cohen, Neale D, Bach, Leon, Kumareswaran, Kavita, Stranks, Stephen N, Burt, Morton G, Holmes-Walker, Jane D, McCallum, Roland W, Kaye, Joey, Speight, Jane, Hendreickx, Christel, Januszewski, Andrzej, Kirby, Adreinne, Vogrin, Sara · 2021 · JAMA Pediatrics
Cited by 121

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Importance: Hybrid closed-loop (HCL) therapy has improved glycemic control in children and adolescents with type 1 diabetes; however, the efficacy of HCL on glycemic and psychosocial outcomes has not yet been established in a long-term randomized clinical trial. Objective: To determine the percentage of time spent in the target glucose range using HCL vs current conventional therapies of continuous subcutaneous insulin infusion or multiple daily insulin injections with or without continuous glucose monitoring (CGM). Design, Setting, and Participants: This 6-month, multicenter, randomized clinical trial included 172 children and adolescents with type 1 diabetes; patients were recruited between April 18, 2017, and October 4, 2019, in Australia. Data were analyzed from July 25, 2020, to February 26, 2021. Interventions: Eligible participants were randomly assigned to either the control group for conventional therapy (continuous subcutaneous insulin infusion or multiple daily insulin injections with or without CGM) or the intervention group for HCL therapy. Main Outcomes and Measures: The primary outcome was the percentage of time in range (TIR) within a glucose range of 70 to 180 mg/dL, measured by 3-week masked CGM collected at the end of the study in both groups. Secondary outcomes included CGM metrics for hypoglycemia, hyperglycemia, and glycemic variability and psychosocial measures collected by validated questionnaires. Results: A total of 135 patients (mean [SD] age, 15.3 [3.1] years; 76 girls [56%]) were included, with 68 randomized to the control group and 67 to the HCL group. Patients had a mean (SD) diabetes duration of 7.7 (4.3) years and mean hemoglobin A1c of 64 (11) mmol/mol, with 110 participants (81%) receiving continuous subcutaneous insulin infusion and 72 (53%) receiving CGM. In the intention-to-treat analyses, TIR increased from a mean (SD) of 53.1% (13.0%) at baseline to 62.5% (12.0%) at the end of the study in the HCL group and from 54.6% (12.5%) to 56.1% (12.2%) in the control group, with a mean adjusted difference between the 2 groups of 6.7% (95% CI, 2.7%-10.8%; P = .002). Hybrid closed-loop therapy also reduced the time that patients spent in a hypoglycemic (<70 mg/dL) range (difference, -1.9%; 95% CI, -2.5% to -1.3%) and improved glycemic variability (coefficient of variation difference, -5.7%; 95% CI, -10.2% to -0.9%). Hybrid closed-loop therapy was associated with improved diabetes-specific quality of life (difference, 4.4 points; 95% CI, 0.4-8.4 points), with no change in diabetes distress. There were no episodes of severe hypoglycemia or diabetic ketoacidosis in either group. Conclusions and Relevance: In this randomized clinical trial, 6 months of HCL therapy significantly improved glycemic control and quality of life compared with conventional therapy in children and adolescents with type 1 diabetes. Trial Registration: ANZCTR identifier: ACTRN12616000753459.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamapediatrics.2021.3965

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 121

Metadata

Authors
Abraham, M. B., de Bock, M., Smith, G. J., Dart, J., Fairchild, J. M., King, B. R., Ambler, G. R., Cameron, F. J., McAuley, S. A., Keech, A. C., Jenkins, A., Davis, E. A., O’Neal, D. N., Jones, T. W., Australian Juvenile Diabetes Research Fund Closed-Loop Research group, Choo, A., Nicholas, J., Laurenson, L., Roberts, A., Bebbingtom, K., Klimek, J., Heels, K., Gebert, R., Johnson, S., Oats, S., Rafferty, J., Pease, A., Zoungas, S., Lee, M. H., Paldus, B., Sims, C. M., MacIssac, R. J., Ward, G. M., Colman, P. G., Cohen, N. D., Bach, L., Kumareswaran, K., Stranks, S. N., Burt, M. G., Holmes-Walker, J. D., McCallum, R. W., Kaye, J., Speight, J., Hendreickx, C., Januszewski, A., Kirby, A., & Vogrin, S.
Venue
JAMA Pediatrics
Published
2021-12-01
Volume
175
Issue
12
Pages
1227
ISSN
  • 1072-4710 (ISSN-L)
  • 2168-6203
OpenAlex
W3206842207
Cited by
121
References
18
FWCI
13.40
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jamapediatrics.2021.3965
The paper
Abraham, M. B., de Bock, M., Smith, G. J., Dart, J., Fairchild, J. M., King, B. R., Ambler, G. R., Cameron, F. J., McAuley, S. A., Keech, A. C., Jenkins, A., Davis, E. A., O’Neal, D. N., Jones, T. W., Australian Juvenile Diabetes Research Fund Closed-Loop Research group, Choo, A., Nicholas, J., Laurenson, L., Roberts, A., . . . Vogrin, S. (2021). Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2021.3965

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.